🔎 Trials Near Me

Akèy › Obèsite

Etid klinik pou Obèsite ap rekrite nan Etazini

480 etid pou Obèsite ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Sep 30, 2026 · NCT06003686

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study

Ap rekriteVolontè an sante akeyi
Laj 18 a 35 · Tout sèks · Mizajou Sep 30, 2026 · NCT07849439

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07752979

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06724406

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

Diabetes and Heart Disease Risk in Blacks

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001853

New Heart Imaging Techniques to Evaluate Possible Heart Disease

Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01399385

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07837973

Comparing Reduction With ESD- Versus APC-TORe

Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06131281

Early Tracking of Childhood Health Determinants (ETCHED) Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT03481829

Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles

Ap rekriteVolontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT07844616

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

Stanford Healthy Goals Study

Ap rekrite
Laj 10 a 15 · Tout sèks · Mizajou Sep 28, 2026 · NCT07839832

Physical and Behavioral Traits of Overweight and Obese Adults

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00428987

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07594093

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.